BeStock  
Markets › Compare › FTH vs OCS

FTH vs OCS

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
FTH · Faeth Therapeutics$7.88 ▼ 9.32%
OCS · Oculis$7.06 ▼ 5.11%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

11126241356471Nov 24, '25May 26, '26Nov 20, '26
  • FTH -12.2%
  • OCS -63.4%

Head to head

MetricFTHOCS
Price$7.88$7.06
Change today▼ 9.32%▼ 5.11%
Market cap$203.65M$437.15M
Return, 3 months-77.3%-46.4%
Return, year to date-26.1%-64.6%
Return, 1 year-9.6%-63.3%
P/E (TTM)––
P/B1.31.8
P/E percentile vs own 5y92nd64th
Dividend yield––
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)-346.4%-8.2%
Gross margin––
Operating margin––
Net margin––
Return on equity-229.6%-47.5%
Analyst target vs. price+633.2%+461.9%
Analyst buy share100%100%
RSI (14)2336
30-day volatility192.7%58.7%
Max drawdown, 1 year-80.3%-79.1%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • OCS is the largest of the group by market value.
  • FTH has returned the most over the past year.
  • OCS has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top